InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: None

Friday, 10/23/2015 11:10:32 AM

Friday, October 23, 2015 11:10:32 AM

Post# of 118384
Well, we've got CRL study data on Sep 25th; we were told the results were positive with no adverse effects; FDA is supposed to respond within 30 days and CRL can submit data electronically to FDA, we also have a PR that RGBP is hiring a new president whose job is to secure funds in a way that will not dilute the company (while the company promises up to 21 million preferred Series A shares in return), so unless it takes more than a week to prepare the data further to submit to FDA, one would think we would have FDA news within the next week, 2 weeks at the most.

Back in April I anticipated Sep-Oct for FDA approval of HemaX based on my estimates for the time the CRL study would take. I still think we should have news by end of October given that 2/3rds of IND was already approved per company statements.

Let's hope.